Anti-Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD

Parambir S. Dulai, Corey A. Siegel, Laurent Peyrin-Biroulet*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-Tumor Necrosis Factor-α Monotherapy Versus Combination Therapy with an Immunomodulator in IBD'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS